Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

NCT07379268 · clinicaltrials.gov ↗

RECRUITING

Status

224

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

OTHER: Organoid culture

Sponsor

Qilu Hospital of Shandong University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]